Applicant, as named in the Orange Book

Rempex

Next listed expiry: Minocin on 16 Oct 2032. 2 products with live protection, 0 without.

Products with listed protection

Drug	Ingredient	NDA	Earliest generic entry	Basis
Minocin minocycline hydrochloride	minocycline hydrochloride	050444	16 Oct 2032	patent
Vabomere meropenem; vaborbactam	meropenem; vaborbactam	209776	6 Apr 2039	patent, carve-out possible

No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.